Financial

LiveWell Awarded Frost & Sullivan’s 2024 Global Customer Value Leadership Award for Advancing Equitable and Accessible Mental Health Solutions

LiveWell's app integrates cutting-edge artificial intelligence (AI) and machine learning to provide personalized mental and behavioral health support, fostering user...

Palisade Bio Provides Update on Progress Toward Launch of Phase 1 Human Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis

– Completion of nonclinical safety and toxicity studies, Phase 1 clinical trial design and established Maximum Recommended Starting Dose –...

INOVAIT and the Government of Canada announce the latest recipients of the INOVAIT Pilot Fund for advancements in image-guided therapy and artificial intelligence

TORONTO, Sept. 23, 2024 /PRNewswire/ - INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and...

Laboratory Information System Market Surges to USD 3.6 Billion by 2030, Propelled by 6.5% CAGR – Verified Market Reports®

The Laboratory Information System (LIS) market is primarily driven by the increasing demand for automation in laboratory processes, which enhances...

International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate Myeloma Support for Patients, Care Partners, and Healthcare Professionals

Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI CompanionSTUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE)...

BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia Submitted protocol to FDA...

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy developmentHOLLISTON, Mass.,...

error: Content is protected !!